CalciMedica

CalciMedica

CalciMedica

CalciMedica is engaged in the discovery and development of small molecule drugs for the treatment of inflammatory and autoimmune disorders.
Type
B2c
Founded
2006
Raised
$36.5M
Follow us
Alexa global traffic share
Latest funding Show all
$2,499,999
Venture capital - 2014
Team Size
1–10
Employees
$15,000,000 Venture capital (Series C)
FinSMEs

CalciMedica Raises $15M in Series C Financing